60 Degrees Pharma Regains Compliance With Nasdaq Listing Requirements
Portfolio Pulse from Benzinga Newsdesk
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) has regained compliance with Nasdaq's minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's stock had previously failed to maintain the required $1.00 minimum bid price for 30 consecutive business days. Compliance was achieved by maintaining a closing bid price of $1.00 or more for at least 10 consecutive trading days, with a closing bid price of $1.09 on January 9, 2024.
January 16, 2024 | 12:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
60 Degrees Pharmaceuticals, Inc. has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.
Regaining compliance with Nasdaq's listing requirements is a positive development for 60 Degrees Pharmaceuticals, Inc. It removes the immediate risk of delisting, which can restore investor confidence and potentially lead to a more stable or positive stock price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100